UBS Group’s Direxion Daily Biotech Top 5 Bull 2X ETF TBXU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$16.8K Sell
422
-284
-40% -$10.8K ﹤0.01% 8644
2026
Q2
$22.7K Buy
+706
New +$21.3K ﹤0.01% 8082

Other funds holding TBXU

UBS Group's TBXU Position: Q3 2026 in Review

UBS Group reduced its Direxion Daily Biotech Top 5 Bull 2X ETF (TBXU) stake by 40% in Q3 2026, selling an estimated $10.8K and leaving 422 shares worth $16.8K. The position accounts for ﹤0.01% of the portfolio, ranked #8644.

UBS Group first reported a position in TBXU in Q2 2026 and has held it in 2 quarters since. The position peaked at $22.7K in Q2 2026. 4 funds tracked by Wall St. Rank hold TBXU as of Q3 2026.

  • UBS Group held 422 shares of Direxion Daily Biotech Top 5 Bull 2X ETF worth $16.8K as of Q3 2026.
  • UBS Group sold 284 Direxion Daily Biotech Top 5 Bull 2X ETF shares in Q3 2026, an estimated $10.8K.
  • Direxion Daily Biotech Top 5 Bull 2X ETF made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #8644 holding.
  • UBS Group first reported a position in Direxion Daily Biotech Top 5 Bull 2X ETF in Q2 2026 and has held it in 2 quarters since.
  • UBS Group's Direxion Daily Biotech Top 5 Bull 2X ETF position peaked at $22.7K in Q2 2026.
  • 4 funds tracked by Wall St. Rank held Direxion Daily Biotech Top 5 Bull 2X ETF as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.